Concept: Medicare Part D
Industry Payments and Prescribing of Brand-Name Multiple Sclerosis Medications in Medicare
How drug company payments to doctors influence multiple sclerosis prescription choices
‘Most Favored Nation’ Drug Pricing Is An Idea Whose Time Has Come
International drug pricing policy and pharmaceutical innovation capacity
